CONCENTRATION OF CREDIT RISK - Triple-Net Leased Properties (Details) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
|
Jun. 30, 2026
property
|
Jun. 30, 2025 |
Jun. 30, 2026
USD ($)
property
|
Jun. 30, 2025
USD ($)
|
|
| Concentration Risk | ||||
| Number of real estate properties | property | 1,420 | 1,420 | ||
| Other Noncash Income (Expense) | $ | $ 3,580 | $ (2,752) | ||
| Customer Concentration Risk | Revenues | Ardent | ||||
| Concentration Risk | ||||
| Percentage of Total NOI | 2.30% | 2.70% | 2.30% | 2.80% |
| Customer Concentration Risk | Revenues | Kindred Healthcare, LLC (“Kindred”) | ||||
| Concentration Risk | ||||
| Percentage of Total NOI | 2.00% | 2.50% | 2.00% | 2.60% |
| Customer Concentration Risk | NOI | Ardent | ||||
| Concentration Risk | ||||
| Percentage of Total NOI | 5.70% | 6.50% | 5.90% | 6.60% |
| Customer Concentration Risk | NOI | Kindred Healthcare, LLC (“Kindred”) | ||||
| Concentration Risk | ||||
| Percentage of Total NOI | 5.10% | 5.90% | 5.20% | 6.10% |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of real estate properties owned as of the balance sheet date. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|